{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-010533","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.589880+00:00","generated_at":"2026-05-31T13:42:14.083506+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"IRADIMED reports record Q2 revenue $17.9M, GAAP EPS $0.38","bullets":["Revenue of $17.9M, up 11.2% YoY; operating income $5.6M, up 13.4%.","GAAP diluted EPS $0.38; non-GAAP diluted EPS $0.42 vs $0.36 in Q2 2023.","Q3 2024 guidance: revenue $18.0-18.2M, GAAP EPS $0.34-0.37.","FY 2024 reaffirmed: revenue $72-74M, GAAP EPS $1.37-1.47.","Declares quarterly dividend $0.15/share payable Aug 30, record Aug 20."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-010533","json":"https://secwatch.observer/filing/0001558370-24-010533.json","markdown":"https://secwatch.observer/filing/0001558370-24-010533.md","text":"https://secwatch.observer/filing/0001558370-24-010533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837024010533/0001558370-24-010533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837024010533/irmd-20240801x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:42:14.083506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}